Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by EduardoSanchezon Mar 30, 2020 1:33am
106 Views
Post# 30858867

RE:RE:New 5 minutes test for COVID-19 by Abott

RE:RE:New 5 minutes test for COVID-19 by Abott

LexaGene’s technology is best designed for syndromic testing, where people want to identify the cause of infection (and how to treat it if we include antimicrobial assays).  In other words - applications where a high Plex is desirable.

 

The Abbott machine is used primarily for flu diagnoses. It is a machine that is designed to detect one specific target. COVID will become seasonal - and healthcare practitioners are going to want to detect both COVID and flu at the same time, but these tests don’t do that. They effectively need to double the cost (and time, to do both).

 

In regards to respiratory infections - a high Plex is desirable (as detecting RSV, and Adenovirus is also important - and there are many more respiratory pathogens that cause disease - and if you get a negative result, it is very frustrating, as you don’t know if the test wasn’t sensitive enough - or if the person is sick with a pathogen that wasn’t included in the test. 

 

If you were a doctor, would you rather know the answer in 15 minutes with many false positives/ false negatives or wait 60 minutes and have the answer to what the issue is with the patient, i.e. Covid19, influenza, respiratory issues etc. Lex’s technology will test for up to 27 different pathogens which will really help the doctor diagnose the illness as well as provide antibiotic resistance

<< Previous
Bullboard Posts
Next >>